Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
37.9M
-
Shares change
-
+6.57M
-
Total reported value, excl. options
-
$1.4B
-
Value change
-
+$242M
-
Put/Call ratio
-
0.63
-
Number of buys
-
71
-
Number of sells
-
-52
-
Price
-
$36.98
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q4 2018
151 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q4 2018.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.9M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (3.14M shares), STIFEL FINANCIAL CORP (2.72M shares), BlackRock Inc. (2.39M shares), RP Management, LLC (2.11M shares), JPMORGAN CHASE & CO (1.9M shares), Vivo Capital, LLC (1.81M shares), WELLINGTON MANAGEMENT GROUP LLP (1.58M shares), ALLIANCEBERNSTEIN L.P. (1.39M shares), TIAA CREF INVESTMENT MANAGEMENT LLC (1.14M shares), and VHCP Management II, LLC (1.14M shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.